Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs) is a group of medicine that plays an important role in treating non-small cell lung cancer (NSCLC). It can be the best replacement for chemotherapy drugs and reduce the side effects caused by it. EGFR is a protein that plays a pivotal role in regulating cell growth, survival, and differentiation.